+65.3%
GSK vs BIDU
-27.4%
+92.7%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BIDU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.7% | -0.1% | +0.5% |
| 7D | +1.1% | -4.6% | +5.7% | +1.4% |
| 30D | +6.3% | -4.5% | +10.9% | +6.6% |
| 3M | +1.8% | -25.4% | +27.2% | +3.3% |
| 6M | +1.7% | -48.1% | +49.7% | +5.4% |
| YTD | +6.5% | -40.2% | +46.7% | +8.8% |
| 1Y | +9.5% | -35.2% | +44.7% | +11.1% |
| 3Y | +65.3% | -27.1% | +92.4% | +62.7% |
| All | +65.3% | -27.4% | +92.7% | +62.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BIDU.
Daily Out/Under-Performance
Portfolio return minus BIDU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BIDU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BIDU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling